SIRT1 and acute kidney injury: Activators of kidney AMPK might thus represent a novel therapeutic approach in patients susceptible to AKI.889 Moreover, the protection of NAD + in AKI is associated with SIRT1 expression and acts in a SIRT1-dependent manner.